FDA gives accelerated approval to Zepzelca for the treatment of metastatic small cell lung cancer. Jazz Pharma + PharmaMar
Jazz Pharmaceuticals plc announced along with its partner PharmaMar that the FDA approved Zepzelca (lurbinectedin) for the treatment of adult patients with metastatic small cell lung cancer (SCLC)… read more.